The eye drops recalled in this latest FDA announcement are an alpha-adrenergic receptor, which are used to reduce elevated intraocular pressure in patients with pen-angle glaucoma or ocular hypertension.Īccording to the recall notice, officials warn several lots of Brimonidine Tartrate Ophthalmic Solution 0.15% may have developed cracks in the lids that seal the product. While it has yet to be determined exactly how the bacteria entered the recalled Artificial Tears products, federal health officials have warned that introducing any bacterial contamination directly to the eyes can result in serious eye infections which can cause vision loss and spread through the bloodstream. The announcement comes only weeks after a nationwide recall of EzriCare and Delsam Pharm Artificial Tears products was announced by the FDA, after dozens of severe infections were linked to eye drops that contained antibiotic resistant strain of Pseudomonas aeruginosa. Food and Drug Administration (FDA) announced the Brimonidine Tartrate Ophthalmic Solution eye drops recall on March 2, indicating the defective caps sealing the eye drops bottles may have developed cracks during the manufacturing process, creating sterility and bacterial concerns. Amid continuing concerns about an ongoing eye infection outbreak linked to contaminated Artificial Tears products, another manufacturer has issued an eye drops recall for Brimonidine Tartrates solutions commonly used to treat glaucoma, warning that defective seals could lead to bacteria entering the bottles.
0 kommentar(er)
